%0 Journal Article
%T The association between comprehensive medication review and medication adherence among medicare beneficiaries with chronic obstructive pulmonary disease.
%A Zhang X
%A Sim Y
%A Tsang CCS
%A Wang J
%A Finch CK
%J Explor Res Clin Soc Pharm
%V 15
%N 0
%D 2024 Sep
%M 39050144
暂无%R 10.1016/j.rcsop.2024.100470
%X <B>UNASSIGNED: </B>Medicare Part D plans are required to provide Medication therapy management (MTM) services to eligible beneficiaries to optimize medication utilization. Comprehensive medication review (CMR) is a core element of the MTM program. Despite the availability of advanced medical treatment for patients with chronic obstructive pulmonary disease (COPD), medication adherence to maintenance medications poses a continued challenge for patients with COPD.<BR><B>UNASSIGNED: </B>To examine the effects of CMR on medication adherence among patients with COPD.<BR><B>UNASSIGNED: </B>Medicare data for 2016-2017 linked to Area Health Resource Files were analyzed. The study population was Medicare beneficiaries with COPD. The intervention group consisted of beneficiaries who received CMR in 2017 but not in 2016. Patients who were eligible for MTM services but did not receive these services in 2016 or 2017 made up the control group. Propensity score matching was used to select an intervention and control group with balanced characteristics. The study outcome was adherence to COPD medications with the proportion of days covered at or above 80%. A difference-in-differences approach was adopted in the logistic regression analyses with an interaction term between the status of CMR receipt and the year 2017.<BR><B>UNASSIGNED: </B>The study sample included 25,564 patients with COPD. The proportions of adherent patients were similar in the control group in both years but increased significantly from 60.08% in 2016 to 69.38% in 2017 in the intervention group (P < .001). The odds of medication adherence in the intervention group increased from 2016 to 2017 by 59% more than in the control group (adjusted odds ratio = 1.59, 95% confidence interval = 1.48-1.71).<BR><B>UNASSIGNED: </B>Receiving CMR was associated with improved adherence to COPD medications among Medicare beneficiaries. Policymakers should ensure that Medicare beneficiaries with COPD receive CMR.